Revisiting growth hormone nadir cut-offs for remission in patients with acromegaly.
Jiwon KimYoon-A HwangYae Won ParkJu Hyung MoonKyung Hwan KimJae Won HongEun Jig LeeCheol-Ryong KuPublished in: European journal of endocrinology (2022)
Different GH nadir cut-offs were associated with different 5-year rates of patients who achieved nadir GH <1.0 μg/L and age- and sex-matched normal IGF-1, suggesting that a strict GH nadir threshold of 0.4 μg/L correlates better with remission.